VRK1 is required in VRK2-methylated cancers of the nervous system
So, J.; Mabe, N.; Englinger, B.; Trissal, M.; Jeong, D.; Panditharatna, E. A.; Marques, J. G.; Justin, H.; Kwon, J.; Moyer, S. M.; Shim, B.; Mayhew, D. L.; Stegmaier, K.; Filbin, M. G.; Hahn, W. C.
Show abstract
Collateral lethality occurs when loss of one paralog renders cancer cells dependent on the remaining paralog. Combining genome scale CRISPR/Cas9 screens coupled with RNA-sequencing in over 900 cancer cell lines, we found that cancers of nervous system lineage, including adult and pediatric gliomas and neuroblastomas, required the nuclear kinase Vaccinia-Related Kinase 1 (VRK1) for their survival. VRK1 dependency was inversely correlated with expression of its paralog VRK2. VRK2 knockout (KO) sensitized cells to VRK1 suppression, and conversely, VRK2 overexpression increased cell fitness in the setting of VRK1 suppression. DNA methylation of the VRK2 promoter was associated with low VRK2 expression in human neuroblastomas, and adult and pediatric gliomas. Mechanistically, depletion of VRK1 reduced Barrier-to-Autointegration Factor (BAF) phosphorylation during mitosis, resulting in DNA damage and apoptosis. Together, these studies identify VRK1 as a synthetic lethal target in VRK2 promoter-methylated adult and pediatric gliomas and neuroblastomas. Statement of SignificanceWe credential VRK1 as a target in adult and pediatric gliomas, and neuroblastomas with VRK2 promoter methylation. This demonstrates the utility of paralog-driven synthetic lethal interactions for biomarker-linked, targeted therapeutics.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug resistant gliomas 96%
- Select EZH2 inhibitors enhance the viral mimicry effects of DNMT inhibition through a mechanism involving calcium-calcineurin-NFAT signaling 94%
- Clinically-relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance 94%
Similar papers in this journal
Similar papers in this journal
- The expression profile and tumorigenic mechanisms of CD97 (ADGRE5) in glioblastoma render it a targetable vulnerability 96%
- Super elongation complex as a targetable dependency in diffuse midline glioma 96%
- NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas 95%
Similar papers in this journal
Similar papers in this journal
- Therapy-induced transdifferentiation promotes glioma growth independent of EGFR signaling 96%
- Premalignant Nf1,Trp53-null Oligodendrocyte Precursor Cells BecomeStalled in a Heterogeneous State of Replication Stress BeforeGliomagenesis 95%
- Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in Glioblastoma. 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.